Headinvest, LLC Abb Vie Inc. Transaction History

Headinvest, LLC

$525 Million
Q3 2024

A detailed history of Headinvest, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Headinvest, LLC holds 9,911 shares of ABBV stock, worth $1.78 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

9,911

Previous 10,045 1.33%

Holding current value

$1.78 Million

Previous $1.72 Million 13.65%

% of portfolio

0.37%

Previous 0.35%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$163.84 - $199.33 $21,954 - $26,710	-134 Reduced 1.33%	9,911 $1.96 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $50,616 - $59,108	-327 Reduced 3.15%	10,045 $1.72 Million
Q1 2024 Aug 14, 2024	SELL	$159.82 - $182.1 $69,521 - $79,213	-435 Reduced 4.03%	10,372 $1.89 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $105,952 - $119,326	-770 Reduced 6.65%	10,807 $1.67 Million
Q3 2023 Dec 11, 2023	SELL	$133.59 - $154.65 $133,055 - $154,031	-996 Reduced 7.92%	11,577 $1.73 Million
Q2 2023 Aug 23, 2023	SELL	$132.51 - $164.9 $136,485 - $169,847	-1,030 Reduced 7.57%	12,573 $1.69 Million
Q1 2023 May 17, 2023	SELL	$144.61 - $166.54 $112,940 - $130,067	-781 Reduced 5.43%	13,603 $2.17 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $3,872 - $4,644	-28 Reduced 0.19%	14,384 $2.33 Million
Q3 2022 Dec 28, 2022	BUY	$134.21 - $153.93 $9,797 - $11,236	73 Added 0.51%	14,412 $1.93 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $5,367 - $6,823	-39 Reduced 0.27%	14,339 $2.2 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $19,533 - $24,235	148 Added 1.04%	14,378 $2.33 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $39,749 - $50,294	370 Added 2.67%	14,230 $1.93 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $12,980 - $14,735	122 Added 0.89%	13,860 $1.5 Million
Q2 2021 Aug 30, 2021	BUY	$105.21 - $117.21 $16,938 - $18,870	161 Added 1.19%	13,738 $1.55 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $339,942 - $374,236	3,323 Added 32.41%	13,577 $1.47 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $155,184 - $209,515	1,928 Added 18.8%	12,182 $1.31 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $155,184 - $209,515	-1,928 Reduced 15.83%	10,254 $898,000
Q3 2020 Nov 24, 2020	BUY	$85.91 - $100.83 $96,648 - $113,433	1,125 Added 12.32%	10,254 $898,000
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $27,073 - $36,228	369 Added 4.21%	9,129 $896,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $136,159 - $206,434	2,111 Added 31.75%	8,760 $667,000
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $123,969 - $187,952	-1,922 Reduced 22.42%	6,649 $506,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $2,163 - $2,707	30 Added 0.35%	8,571 $759,000
Q3 2019 Nov 21, 2019	BUY	$62.98 - $75.72 $109,081 - $131,147	1,732 Added 25.44%	8,541 $647,000
Q2 2019 Aug 22, 2019	BUY	$65.7 - $83.98 $10,512 - $13,436	160 Added 2.41%	6,809 $495,000
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $512,903 - $603,662	-6,649 Reduced 50.0%	6,649 $536,000
Q4 2018 Feb 22, 2019	BUY	$77.85 - $96.01 $516,067 - $636,450	6,629 Added 99.4%	13,298 $1.23 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $9,602 - $10,674	-108 Reduced 1.59%	6,669 $631,000
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $1,795 - $2,124	20 Added 0.3%	6,777 $628,000
Q1 2018 Apr 09, 2018	SELL	$92.01 - $123.21 $41,404 - $55,444	-450 Reduced 6.24%	6,757 $640,000
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $17,912 - $19,642	-200 Reduced 2.7%	7,207 $697,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $517,378 - $660,852	7,407	7,407 $668,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.

Account